BBA
CTMX icon

Baker Bros. Advisors’s CytomX Therapeutics CTMX Stock Holding History

Baker Bros. Advisors’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.4M Buy
4,975,826
+725,000
+17% +$3.68M 0.13% 46
2025
Q4 		$18.1M Hold
4,250,826
– – 0.11% 55
2025
Q3 		$13.6M Buy
4,250,826
+766,600
+22% +$1.73M 0.1% 57
2025
Q2 		$7.91M Buy
+3,484,226
New +$5.62M 0.08% 58
2020
Q2 		– Sell
-20,000
Closed -$153K – 115
2020
Q1 		$153K Sell
20,000
-174,377
-90% -$1.22M ﹤0.01% 110
2019
Q4 		$1.61M Hold
194,377
– – 0.01% 87
2019
Q3 		$1.44M Hold
194,377
– – 0.01% 92
2019
Q2 		$2.18M Hold
194,377
– – 0.01% 83
2019
Q1 		$2.09M Buy
+194,377
New +$2.87M 0.01% 80

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return